Evaluation of saliva levels and therapeutic effects of morinidazole, a new 5-nitroimidazole derivative, in patients with periodontal diseases

Yong-qing Wang*; Ya-ning Mei; Meng Song; Pei-pei Zhang; Ning-ling Jiang; Ling Meng; Ning Ou; Hai-bo Zhang; Lin Yin

doi:DOI: 10.5897/AJPP12.1353

African Journal of
Pharmacy and Pharmacology

Abbreviation: Afr. J. Pharm. Pharmacol.
Language: English
ISSN: 1996-0816
DOI: 10.5897/AJPP
Start Year: 2007
Published Articles: 2286

Full Length Research Paper

Evaluation of saliva levels and therapeutic effects of morinidazole, a new 5-nitroimidazole derivative, in patients with periodontal diseases

Yong-qing Wang*

Yong-qing Wang*
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Ya-ning Mei

Ya-ning Mei
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Meng Song

Meng Song
Department of Periodontics, the First Affiliated Hospital with Shanghai Jiao Tong University, China.
Search for this author on:
Google Scholar

Pei-pei Zhang

Pei-pei Zhang
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Ning-ling Jiang

Ning-ling Jiang
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Ling Meng

Ling Meng
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Ning Ou

Ning Ou
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Hai-bo Zhang

Hai-bo Zhang
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Search for this author on:
Google Scholar

Lin Yin

Lin Yin
Department of Periodontics, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China.
Search for this author on:
Google Scholar

Article Number - 834952946189
Vol.8(26), pp. 713-718 , July 2014
https://doi.org/DOI: 10.5897/AJPP12.1353

Received: 17 October 2013
Accepted: 01 July 2014
Published: 15 July 2014

References

Akay C, Özkan SA, Åžentürk Z, CevheroÄŸlu Åž (2003). Simultaneous Determination of Metronidazole and Miconazole in Pharmaceutical Dosage Forms by Rp-Hplc. Il Farmacol. 57:953-957. Crossref

Austin M, Meyn L, Hillier S (2006). Susceptibility of Vaginal Bacteria to Metronidazole and Tinidazole. Anaerobe 12: 227-230. Crossref

Bakshi M, Singh S (2004). Hplc and Lc–Ms Studies on Stress Degradation Behaviour of Tinidazole and Development of a Validated Specific Stability-Indicating Hplc Assay Method. J. Pharm. Biomed. Anal. 34:11-18. Crossref

Beck JD, Offenbacher S (2005). Systemic Effects of Periodontitis: Epidemiology of Periodontal Disease and Cardiovascular Disease. J. Periodontol. 76:2089-2100. Crossref

Ebersole JL (2003). Humoral Immune Responses in Gingival Crevice Fluid: Local and Systemic Implications. Periodontology 2000 31:135-166. Crossref

Ford PJ, Raphael SL, Cullinan MP, Jenkins AJ, West MJ, Seymour GJ (2010). Why should a doctor be interested in oral disease? Expert Rev. Cardiovasc. Ther. 8:483-1493. Crossref

Fung HB, Doan TL (2005). Tinidazole: A Nitroimidazole Antiprotozoal Agent. Clin. Ther. 27:1859. Crossref

Hart R, Doherty DA, Pennell CE, Newnham LA, Newnham JP (2012). Periodontal Disease: a potential modifiable risk factor limiting conception. Hum. Reprod. 27:1332-1342. Crossref

Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO, Jensen R, Waterer G, Rubin SM, Newman AB (2005). Periodontitis and Airway Obstruction. J. Periodontol. 76:2161-2167. Crossref

LeCorn DW, Vertucci FJ, Rojas MF, Progulske-Fox A, Bélanger M (2007). In Vitro Activity of Amoxicillin, Clindamycin, Doxycycline, Metronidazole, and Moxifloxacin against Oral Actinomyces. J. Edodontics 33:557-560. Crossref

Lv W (2010). Investigation of the Effects of 24 Bio-Matrices on the Lc–Ms/Ms Analysis of Morinidazole. Talanta 80:1406-1412. Crossref

Mombelli A, Gusberti F, Lang N (2005). Treatment of Recurrent Periodontal Disease by Root Planing and Ornidazole (Tiberal®). J. Clin. Periodont. 16:38-45. Crossref

Newnham JP, Newnham IA, Ball CM, Wright M, Pennell CE, Swain J, Doherty DA (2009). Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet. Gynecol. 114:1239-1248. Crossref

Pähkla ER, Koppel T, Saag M, Pähkla R (2005). Metronidazole Concentrations in Plasma, Saliva and Periodontal Pockets in Patients with Periodontitis. J. Clin. Periodontol. 32:163-166. Crossref

Patel K, Green-Hopkins I, Lu S, Tunkel AR (2008). Cerebellar Ataxia Following Prolonged Use of Metronidazole: Case Report and Literature Review. Int. J. Infect. Dis. 12:e111-e114. Crossref

Perioli L, Ambrogi V, Rubini D, Giovagnoli S, Ricci M, Blasi P, Rossi C (2004). Novel Mucoadhesive Buccal Formulation Containing Metronidazole for the Treatment of Periodontal Disease. J. Controlled Release 95: 521-533. Crossref

Pradeep A, Daisy H, Hadge P (2009). Serum Levels of Monocyte Chemoattractant Protein-1 in Periodontal Health and Disease. Cytokine 47:77-81. Crossref

Shub A, Wong C, Jennings B, Swain JR, Newnham JP (2009). Maternal periodontal disease and perinatal mortality. Austr N Z J Obstet. Gynaecol. 49:130-136. Crossref

Zhang L, Zhang Z, Wu K (2006). In Vivo and Real Time Determination of Ornidazole and Tinidazole and Pharmacokinetic Study by Capillary Electrophoresis with Microdialysis. J. Pharm. Biomed. Anal. 41:1453-1457. Crossref